Tandem Diabetes Care (TNDM) Earnings Date, Estimates & Call Transcripts $30.15 +2.28 (+8.18%) (As of 11/20/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Tandem Diabetes Care Latest Earnings SummaryLatest Q3 2024 Earnings DateNov. 6ConfirmedActual EPS (Nov. 6) -$0.35 Beat By $0.08 Consensus EPS (Nov. 6) -$0.43 Tandem Diabetes Care released Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.35, which beat the consensus estimate of -$0.43 by $0.08. Quarterly revenue rose 31.4% year-over-year to $243.97 million, above the consensus estimate of $224.14 million. With a trailing EPS of -$1.93, Tandem Diabetes Care's earnings are expected to grow next year, from ($1.73) to ($1.20) per share. Conference Call AudioEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K Filing Get Tandem Diabetes Care Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tandem Diabetes Care and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTNDM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TNDM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Tandem Diabetes Care Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.78-$0.63-$0.71Q2 20242-$0.53-$0.45-$0.49Q3 20242-$0.44-$0.25-$0.35Q4 20242-$0.31-$0.13-$0.22FY 20248-$2.06-$1.46-$1.76Q1 20252-$0.66-$0.42-$0.54Q2 20252-$0.38-$0.37-$0.38Q3 20251-$0.09-$0.09-$0.09Q4 20251-$0.10-$0.10-$0.10FY 20256($1.23)($0.98)($1.11) Tandem Diabetes Care Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks11/6/2024Q3 2024-$0.43-$0.35+$0.08-$0.37$224.14M$243.97M 8/1/2024Q2 2024-$0.54-$0.47+$0.07-$0.47$205.63M$221.90M 5/2/2024Q1 2024-$0.80-$0.63+$0.17-$0.61$173.06M$191.67M 2/21/2024Q4 2023-$0.23-$0.27 -$0.04-$0.08$204.86M$196.80M 11/1/2023Q3 2023-$0.35-$0.38 -$0.03-$0.25$193.33M$185.62M 8/3/2023Q2 2023-$0.54-$0.30+$0.24-$0.05$201.62M$195.92M Get the Latest News and Ratings for TNDM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter. 5/3/2023Q1 2023-$0.56-$0.63 -$0.07$0.66$171.59M$169.38M 2/22/2023Q4 2022-$0.0160-$0.01+$0.0060$0.23$221.99M$223.45M Tandem Diabetes Care Earnings - Frequently Asked Questions When did Tandem Diabetes Care announce their last quarterly earnings? Tandem Diabetes Care (NASDAQ:TNDM) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on TNDM's earnings history. What guidance has Tandem Diabetes Care issued on next quarter's earnings? Tandem Diabetes Care issued an update on its FY 2024 earnings guidance on Wednesday, November, 6th. The company issued revenue guidance of $903.0 million-$910.0 million, compared to the consensus revenue estimate of $891.0 million. Did Tandem Diabetes Care beat their earnings estimates last quarter? In the previous quarter, Tandem Diabetes Care (NASDAQ:TNDM) reported ($0.35) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.43) by $0.08. Learn more on analysts' earnings estimate vs. TNDM's actual earnings. How can I listen to Tandem Diabetes Care's earnings conference call? The conference call for Tandem Diabetes Care's latest earnings report can be listened to online. Listen to Conference Call How can I view Tandem Diabetes Care's earnings report? Tandem Diabetes Care's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Tandem Diabetes Care generate each year? Tandem Diabetes Care (NASDAQ:TNDM) has a recorded annual revenue of $854.35 million. How much profit does Tandem Diabetes Care generate each year? Tandem Diabetes Care (NASDAQ:TNDM) has a recorded net income of -$222.61 million. TNDM has generated -$1.93 earnings per share over the last four quarters. What is Tandem Diabetes Care's EPS forecast for next year? Tandem Diabetes Care's earnings are expected to grow from ($1.73) per share to ($1.20) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Integra LifeSciences Earnings Date Nevro Earnings Date ICU Medical Earnings Date Haemonetics Earnings Date Bausch + Lomb Earnings Date Inspire Medical Systems Earnings Date PROCEPT BioRobotics Earnings Date Axonics Earnings Date Envista Earnings Date Inari Medical Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW This page (NASDAQ:TNDM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
